 |
0 Diseases |  |
37 Trials |
|
37 Trials |  |
1094 News |  |
| «12...891011121314151617181920» |
- | hydrochlorothiazide / Generic mfg., clonidine / Generic mfg.
New P4 trial: ATLAS: Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System (clinicaltrials.gov) - Apr 12, 2017
P4, N=72, Recruiting, Sponsor: University of Iowa
- | hydrochlorothiazide / Generic mfg., clonidine / Generic mfg.
Trial primary completion date: VANISH: Vascular Dysfunction in Human Obesity Hypertension (clinicaltrials.gov) - Mar 29, 2017
P2, N=126, Recruiting, Sponsor: Gary L. Pierce
Trial primary completion date: Sep 2017 --> Jul 2018
- | hydrochlorothiazide / Generic mfg.
Enrollment open: NOSTONE: Randomized Double-blind Placebo-controlled Trial Assessing the Efficacy of Standard and Low Dose Hydrochlorothiazide Treatment in the Prevention of Recurrent Nephrolithiasis (clinicaltrials.gov) - Mar 21, 2017
P3, N=416, Recruiting, Sponsor: University Hospital Inselspital, Berne
Trial primary completion date: Sep 2017 --> Jul 2018 Not yet recruiting --> Recruiting
- | hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
New trial: The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients (clinicaltrials.gov) - Mar 17, 2017
P=N/A, N=52, Recruiting, Sponsor: University of Sao Paulo General Hospital
- ||| Enrollment open, Real-world evidence, Real-world: To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension (clinicaltrials.gov) - Feb 20, 2017
P=N/A, N=550, Recruiting, Sponsor: Boehringer Ingelheim
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | hydrochlorothiazide / Generic mfg.
New P3 trial: NOSTONE: Randomized Double-blind Placebo-controlled Trial Assessing the Efficacy of Standard and Low Dose Hydrochlorothiazide Treatment in the Prevention of Recurrent Nephrolithiasis (clinicaltrials.gov) - Feb 19, 2017
P3, N=416, Not yet recruiting, Sponsor: University Hospital Inselspital, Berne
- || Enrollment change, Real-world evidence, Real-world: To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension (clinicaltrials.gov) - Feb 12, 2017
P=N/A, N=500, Not yet recruiting, Sponsor: Boehringer Ingelheim
Not yet recruiting --> Recruiting N=650 --> 500
- CoAprovel (irbesartan hydrochlorothiazide) / Sanofi, Azilva (azilsartan) / Takeda
Enrollment open, Combination therapy: PUZZLE: Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity. (clinicaltrials.gov) - Feb 7, 2017
P=N/A, N=94, Recruiting, Sponsor: Russian Heart Failure Society
N=650 --> 500 Not yet recruiting --> Recruiting
- Trial completion: SMAC AF: Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF (clinicaltrials.gov) - Jan 31, 2017
P4, N=184, Completed, Sponsor: Nova Scotia Health Authority
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- hydrochlorothiazide / Generic mfg.
Trial primary completion date: Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism (clinicaltrials.gov) - Jan 23, 2017
P=N/A, N=15, Recruiting, Sponsor: University of Missouri-Columbia
Active, not recruiting --> Completed Trial primary completion date: May 2017 --> May 2018
- Trial completion, Phase classification, Trial primary completion date: Treatment of Supine Hypertension in Autonomic Failure (clinicaltrials.gov) - Jan 18, 2017
P1, N=152, Completed, Sponsor: Vanderbilt University
Trial primary completion date: May 2017 --> May 2018 Recruiting --> Completed | Phase classification: P1/2 --> P1 | Trial primary completion date: Sep 2017 --> Jan 2017
- ||| New trial, Real-world evidence, Real-world: To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension (clinicaltrials.gov) - Jan 13, 2017
P=N/A, N=650, Not yet recruiting, Sponsor: Boehringer Ingelheim
- CoAprovel (irbesartan hydrochlorothiazide) / Sanofi, Azilva (azilsartan) / Takeda
New trial, Combination therapy: PUZZLE: Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity. (clinicaltrials.gov) - Dec 30, 2016
P=N/A, N=94, Not yet recruiting, Sponsor: Russian Heart Failure Society
- hydrochlorothiazide / Generic mfg.
Enrollment change: Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes (clinicaltrials.gov) - Dec 21, 2016
P=N/A, N=17, Terminated, Sponsor: University of Maryland
Recruiting --> Completed | Phase classification: P1/2 --> P1 | Trial primary completion date: Sep 2017 --> Jan 2017 N=24 --> 17
- Trial primary completion date: UFLC: Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Dec 5, 2016
P4, N=30, Recruiting, Sponsor: Tulane University Health Sciences Center
N=24 --> 17 Trial primary completion date: Dec 2015 --> Feb 2017
- hydrochlorothiazide / Generic mfg., losartan potassium / Generic mfg., perindopril arginine / Generic mfg.
Trial primary completion date: ACES-P: ACE Inhibitors Combined With Exercise for Seniors - Pilot Study (clinicaltrials.gov) - Nov 30, 2016
P2, N=72, Recruiting, Sponsor: University of Florida
Trial primary completion date: Dec 2015 --> Feb 2017 Trial primary completion date: Dec 2017 --> Jun 2017
- | hydrochlorothiazide / Generic mfg., olmesartan medoxomil/amlodipine/hydrochlorothiazide / Generic mfg.
New P1 trial: BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions (clinicaltrials.gov) - Nov 13, 2016
P1, N=34, Completed, Sponsor: Torrent Pharmaceuticals Limited
- | hydrochlorothiazide / Generic mfg., olmesartan medoxomil/amlodipine/hydrochlorothiazide / Generic mfg.
New P1 trial: Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions. (clinicaltrials.gov) - Nov 13, 2016
P1, N=34, Completed, Sponsor: Torrent Pharmaceuticals Limited
- hydrochlorothiazide / Generic mfg., amlodipine besilate / Generic mfg., losartan potassium / Generic mfg.
Enrollment open, Trial primary completion date: N-of-1 Trials for Blood Pressure Medications in Adults (clinicaltrials.gov) - Oct 21, 2016
P2, N=20, Recruiting, Sponsor: Columbia University
Trial primary completion date: Dec 2017 --> Jun 2017 Active, not recruiting --> Recruiting | Trial primary completion date: Nov 2016 --> Nov 2017
- hydrochlorothiazide / Generic mfg., enalapril / Generic mfg.
Trial primary completion date: Feasibility Study of the Intensive Systolic Blood Pressure Control (clinicaltrials.gov) - Oct 13, 2016
P4, N=100, Enrolling by invitation, Sponsor: Second Affiliated Hospital of Nanchang University
Active, not recruiting --> Recruiting | Trial primary completion date: Nov 2016 --> Nov 2017 Trial primary completion date: Sep 2016 --> Dec 2016
- hydrochlorothiazide / Generic mfg.
Enrollment open: ACTICAS: Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism (clinicaltrials.gov) - Oct 11, 2016
P2, N=12, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: Sep 2016 --> Dec 2016 Not yet recruiting --> Recruiting
- chlorthalidone / Generic mfg., hydrochlorothiazide / Generic mfg.
Trial primary completion date: DCP: Diuretic Comparison Project (clinicaltrials.gov) - Jul 26, 2016
P=N/A, N=13500, Recruiting, Sponsor: VA Office of Research and Development
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2020 --> Oct 2022
- hydrochlorothiazide / Generic mfg., amlodipine besilate / Generic mfg., losartan potassium / Generic mfg.
Enrollment closed: N-of-1 Trials for Blood Pressure Medications in Adults (clinicaltrials.gov) - Jul 20, 2016
P2, N=20, Active, not recruiting, Sponsor: Columbia University
Trial primary completion date: Oct 2020 --> Oct 2022 Recruiting --> Active, not recruiting
- ||||||| hydrochlorothiazide / Generic mfg.
Trial completion: A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension (clinicaltrials.gov) - Jul 14, 2016
P3, N=341, Completed, Sponsor: Takeda
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- hydrochlorothiazide / Generic mfg.
New P2 trial: ACTICAS: Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism (clinicaltrials.gov) - Jul 7, 2016
P2, N=12, Not yet recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
- |||| Kanarb (fimasartan) - Boryung Group, R / Pharm
Trial completion, Combination therapy: A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide (clinicaltrials.gov) - Jul 2, 2016
P2, N=103, Completed, Sponsor: Boryung Pharmaceutical Co., Ltd
Active, not recruiting --> Completed Recruiting --> Completed
- | hydrochlorothiazide / Generic mfg., enalapril / Generic mfg.
New P4 trial: Feasibility Study of the Intensive Systolic Blood Pressure Control (clinicaltrials.gov) - Jun 29, 2016
P4, N=100, Enrolling by invitation, Sponsor: Second Affiliated Hospital of Nanchang University
- chlorthalidone / Generic mfg., hydrochlorothiazide / Generic mfg.
Enrollment open: DCP: Diuretic Comparison Project (clinicaltrials.gov) - Jun 28, 2016
P=N/A, N=13500, Recruiting, Sponsor: VA Office of Research and Development
Recruiting --> Completed Not yet recruiting --> Recruiting
- Bystolic (nebivolol) / Menarini, AbbVie
Trial completion: Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide (clinicaltrials.gov) - May 23, 2016
P4, N=34, Completed, Sponsor: University of California, San Diego
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
Trial primary completion date: Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension (clinicaltrials.gov) - May 13, 2016
P=N/A, N=50, Enrolling by invitation, Sponsor: The University of Texas Health Science Center, Houston
Active, not recruiting --> Completed Trial primary completion date: Feb 2016 --> Jul 2016
- hydrochlorothiazide / Generic mfg., furosemide / Generic mfg., bumetanide / Generic mfg.
New trial: POINCARE: Effects of Fluid Balance Control in Critically Ill Patients (clinicaltrials.gov) - May 6, 2016
P=N/A, N=1716, Not yet recruiting, Sponsor: Central Hospital, Nancy, France
- hydrochlorothiazide / Generic mfg., amlodipine besilate / Generic mfg., losartan potassium / Generic mfg.
New P2 trial: N-of-1 Trials for Blood Pressure Medications in Adults (clinicaltrials.gov) - Apr 20, 2016
P2, N=20, Recruiting, Sponsor: Columbia University
- | hydrochlorothiazide / Generic mfg.
New P4 trial, Combination therapy: Creole: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans (clinicaltrials.gov) - Apr 19, 2016
P4, N=702, Not yet recruiting, Sponsor: University of Abuja
- hydrochlorothiazide / Generic mfg.
Enrollment change, Trial primary completion date: CLOROTIC: Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart Failure (clinicaltrials.gov) - Apr 15, 2016
P4, N=304, Recruiting, Sponsor: Spanish Society of Internal Medicine
Trial primary completion date: Feb 2016 --> Jul 2016 N=400 --> 304 | Trial primary completion date: Oct 2015 --> Dec 2016
- hydrochlorothiazide / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: A Translational Approach to Gitelman Syndrome (clinicaltrials.gov) - Mar 30, 2016
P=N/A, N=8, Completed, Sponsor: Oregon Health and Science University
N=400 --> 304 | Trial primary completion date: Oct 2015 --> Dec 2016 Not yet recruiting --> Completed | N=10 --> 8 | Trial primary completion date: Jan 2010 --> Jan 2013
- chlorthalidone / Generic mfg., hydrochlorothiazide / Generic mfg.
New trial: Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=10, Recruiting, Sponsor: VA New York Harbor Healthcare System
- Bystolic (nebivolol) / Menarini, AbbVie
New P4 trial: Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide (clinicaltrials.gov) - Mar 16, 2016
P4, N=34, Active, not recruiting, Sponsor: University of California, San Diego
- hydrochlorothiazide / Generic mfg.
New P4 trial: guanhctz: Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic (clinicaltrials.gov) - Mar 4, 2016
P4, N=34, Active, not recruiting, Sponsor: University of California, San Diego
- chlorthalidone / Generic mfg., hydrochlorothiazide / Generic mfg.
Trial initiation date, Trial primary completion date: DCP: Diuretic Comparison Project (clinicaltrials.gov) - Mar 1, 2016
P=N/A, N=13500, Not yet recruiting, Sponsor: VA Office of Research and Development
Not yet recruiting --> Completed | N=10 --> 8 | Trial primary completion date: Jan 2010 --> Jan 2013 Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2019 --> Oct 2020
- acetazolamide / Generic mfg., hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
Trial primary completion date: Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema (clinicaltrials.gov) - Feb 23, 2016
P4, N=20, Completed, Sponsor: Shiraz University of Medical Sciences
Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2019 --> Oct 2020 Trial primary completion date: Sep 2015 --> Jun 2015
- Hygroton (chlortalidone) / Alliance
Trial initiation date, Trial primary completion date, HEOR: EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network (clinicaltrials.gov) - Feb 13, 2016
P4, N=80, Not yet recruiting, Sponsor: Johns Hopkins University
Trial primary completion date: Sep 2015 --> Jun 2015 Initiation date: Jul 2013 --> Jul 2016 | Trial primary completion date: Jun 2014 --> Jun 2017
- Enrollment closed, Trial primary completion date: SMAC AF: Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF (clinicaltrials.gov) - Feb 3, 2016
P4, N=184, Active, not recruiting, Sponsor: Nova Scotia Health Authority
Initiation date: Jul 2013 --> Jul 2016 | Trial primary completion date: Jun 2014 --> Jun 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Oct 2016
- acetazolamide / Generic mfg., hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
Trial initiation date, Trial primary completion date: Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema (clinicaltrials.gov) - Jan 27, 2016
P4, N=20, Completed, Sponsor: Shiraz University of Medical Sciences
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Oct 2016 Initiation date: Jul 2014 --> Apr 2015 | Trial primary completion date: Mar 2015 --> Sep 2015
- ||||||| valsartan / Generic mfg.
Trial completion: Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age (clinicaltrials.gov) - Jan 15, 2016
P3, N=150, Completed, Sponsor: Novartis Pharmaceuticals
Initiation date: Jul 2014 --> Apr 2015 | Trial primary completion date: Mar 2015 --> Sep 2015 Active, not recruiting --> Completed
- | hydrochlorothiazide / Generic mfg., benidipine / Generic mfg., fosinopril / Generic mfg.
New P4 trial: BEAHIT: Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension (clinicaltrials.gov) - Jan 5, 2016
P4, N=508, Not yet recruiting, Sponsor: Shanghai Changzheng Hospital
- Trial primary completion date: Treatment of Supine Hypertension in Autonomic Failure (clinicaltrials.gov) - Jan 4, 2016
P1/2, N=160, Recruiting, Sponsor: Vanderbilt University
Active, not recruiting --> Completed Trial primary completion date: Sep 2016 --> Sep 2017
- ||||| hydrochlorothiazide / Generic mfg.
Enrollment closed: A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension (clinicaltrials.gov) - Dec 16, 2015
P3, N=330, Active, not recruiting, Sponsor: Takeda
Trial primary completion date: Sep 2016 --> Sep 2017 Recruiting --> Active, not recruiting
- chlorthalidone / Generic mfg., hydrochlorothiazide / Generic mfg.
Trial primary completion date: Chlorthalidone and HCTZ Impacts on Platelet Activation (clinicaltrials.gov) - Dec 14, 2015
P4, N=30, Recruiting, Sponsor: Creighton University
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2016 --> Dec 2016
- hydrochlorothiazide / Generic mfg.
New trial: Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism (clinicaltrials.gov) - Oct 29, 2015
P=N/A, N=15, Recruiting, Sponsor: University of Missouri-Columbia
- chlorthalidone / Generic mfg., hydrochlorothiazide / Generic mfg.
Trial initiation date: DCP: Diuretic Comparison Project (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=13500, Not yet recruiting, Sponsor: VA Office of Research and Development
Trial primary completion date: Jan 2016 --> Dec 2016 Initiation date: Sep 2015 --> Dec 2015